Vaxin Inc. — Form D
Vaxin Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-24. The offering totals $42.0M, of which $42.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-03-24
- Form: D
- Accession: 0001636613-15-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.0M
- Amount sold: $42.0M
- Investors: 60
- Date of first sale: 2015-03-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-236534
Issuer
- Name: Vaxin Inc.
- CIK: 0001636613
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 19 FIRSTFIELD ROAD, GAITHERSBURG, MD, 20878
- Phone: 240-654-1450
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David Drutz | Director | Gaithersburg, MD |
| William Enright | Director | Gaithersburg, MD |
| Florent Gros | Director | Menlo Park, CA |
| Philip Hodges | Director | Gaithersburg, MD |
| Philippe Pouletty | Director | Gaithersburg, MD |
| Klaus Schafer | Director | Gaithersburg, MD |
| Marten Steen | Director | Lausanne, V8 |
| William Enright | Executive Officer | Gaithersburg, MD |
| Scot Roberts | Executive Officer | Gaithersburg, MD |
Other filings by this issuer (1)
More